ALK Abello [ALK B], a speciality pharmaceutical company with two newly
In honor of the occasion,
NASDAQ MarketSite –
ALK Abello Contact:
+45 20 64 11 43
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.
For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq.
For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx.
For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/.
A webcast of the NASDAQ Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx.
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About ALK Abello [ALK B]:
ALK is a research-driven global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. ALK is the world leader in allergy immunotherapy – a unique treatment of the underlying cause of allergy. The company has approximately 1,800 employees with subsidiaries, production facilities and distributors worldwide. ALK has entered into partnership agreements with Merck and Torii to commercialise sublingual allergy immunotherapy tablets in
Most Popular Stories
- 'Lucy's' Super Powers Tops 'Hercules' at Box Office
- The 2014 Fastest-Growing 100
- Vancrest Assisted Living Project to Add 20 Jobs
- Fighting Blocks Investigators, Police From MH17 Crash Site
- The Rise and Fall of Richard Alarcon
- VW Site Could Mean Another 2,000 Jobs for Chattanooga
- Ford Bumps Price of New F-150
- Insecticides Permeate U.S. Food, Water Supply
- Nissan Profits Rise on Growth in U.S., China
- U.N. Renews Demand for Gaza Cease-Fire